INS and cancer: Reduction in the ability of these cells to take glucose from the blood in response to normal circulating levels of insulin is known as insulin resistance (IR).Chronic IR is a key pathological feature of obesity, type 2 diabetes with an increased weight of the patients and cancer cachexia with a reduced weight of the cancer-bearing host (1).